Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Clinical News

Emixustat: Phase IIa data

June 8, 2015 7:00 AM UTC

The double-blind, U.S. Phase IIa 4429-201 trial in 72 patients with GA associated with dry AMD showed that emixustat suppressed the recovery of rod photoreceptor responses from baseline to day 14 by 2...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article